FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023998370> ?p ?o ?g. }

• W2023998370 endingPage "597" @default.
• W2023998370 startingPage "591" @default.
• W2023998370 abstract "In daily routine business, various prostate-specific antigen (PSA) retest strategies are being promoted.To investigate rescreening intervals according to baseline PSA <3 ng/ml stratified by any and aggressive prostate cancer (PCa).From 1998 to 2012, data from 4350 men aged 55-70 yr were analyzed from a population-based prospective screening study (median follow-up: 11.6 yr).The primary end point was detection of aggressive PCa (Gleason score 7-10). Cox regression analysis was used to examine the relationship between covariates.Baseline PSA of <1.0 ng/ml, 1-1.9 ng/ml, and 2-2.9 ng/ml was present in 2416 men (55.5%: group 1), 1371 men (31.6%: group 2), and 563 men (12.9%: group 3), respectively. Stratified according to these PSA groups, aggressive PCa was detected in 25 patients (1.0%), 80 patients (5.8%), and 34 patients (6.0%), respectively. During 4 yr, these numbers were 0.0%, 0.29%, and 1.8%, whereas during 8 yr, the numbers were 0.2%, 1.4%, and 2.5%, respectively. In multivariable Cox regression analysis, the only independent risk factor for aggressive PCa was baseline PSA (hazard ratio [HR]: 6.06; 95% confidence interval [CI], 3.82-9.61; p<0.0001, group 2 vs group 1; and HR: 7.33; 95% CI, 4.29-12.52; p<0.0001, group 3 vs group 1).Baseline PSA was the only predictor regarding aggressive PCa. According to the low rate of potentially missed PCa in these groups, rescreening intervals can be safely adapted to baseline PSA values corresponding to a PSA pyramid: 6-8 yr if baseline PSA is <1.0 ng/ml, 3-4 yr if baseline PSA is 1-1.99 ng/ml, and yearly if baseline PSA is 2-2.99 ng/ml.We observed men with a prostate-specific antigen (PSA) value ≤3 ng/ml during 12 yr and found that men can be retested according to their initial PSA value (PSA pyramid): PSA <1 (base), retest interval every 8 yr; PSA 1-2 (center), retest interval every 4 yr; and PSA 2-3 (top), retest yearly after risk stratification." @default.
• W2023998370 created "2016-06-24" @default.
• W2023998370 creator A5007076175 @default.
• W2023998370 creator A5013463417 @default.
• W2023998370 creator A5031384782 @default.
• W2023998370 creator A5037303670 @default.
• W2023998370 creator A5046400409 @default.
• W2023998370 creator A5062173340 @default.
• W2023998370 creator A5065710640 @default.
• W2023998370 creator A5087988526 @default.
• W2023998370 date "2015-10-01" @default.
• W2023998370 modified "2023-10-01" @default.
• W2023998370 title "A “PSA Pyramid” for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening" @default.
• W2023998370 cites W143178506 @default.
• W2023998370 cites W1555872688 @default.
• W2023998370 cites W1978177793 @default.
• W2023998370 cites W2000635377 @default.
• W2023998370 cites W2001012554 @default.
• W2023998370 cites W2003985842 @default.
• W2023998370 cites W2007475890 @default.
• W2023998370 cites W2017657614 @default.
• W2023998370 cites W2018791142 @default.
• W2023998370 cites W2026707626 @default.
• W2023998370 cites W2027117075 @default.
• W2023998370 cites W2042748219 @default.
• W2023998370 cites W2053948486 @default.
• W2023998370 cites W2055968355 @default.
• W2023998370 cites W2067076538 @default.
• W2023998370 cites W2075125965 @default.
• W2023998370 cites W2078137953 @default.
• W2023998370 cites W2081090955 @default.
• W2023998370 cites W2090535842 @default.
• W2023998370 cites W2090538460 @default.
• W2023998370 cites W2106058419 @default.
• W2023998370 cites W2108391240 @default.
• W2023998370 cites W2117792530 @default.
• W2023998370 cites W2121103668 @default.
• W2023998370 cites W2127082932 @default.
• W2023998370 cites W2127715602 @default.
• W2023998370 cites W2129306079 @default.
• W2023998370 cites W2140687262 @default.
• W2023998370 cites W2159085160 @default.
• W2023998370 doi "https://doi.org/10.1016/j.eururo.2014.04.005" @default.
• W2023998370 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24794075" @default.
• W2023998370 hasPublicationYear "2015" @default.
• W2023998370 type Work @default.
• W2023998370 sameAs 2023998370 @default.
• W2023998370 citedByCount "25" @default.
• W2023998370 countsByYear W20239983702014 @default.
• W2023998370 countsByYear W20239983702015 @default.
• W2023998370 countsByYear W20239983702016 @default.
• W2023998370 countsByYear W20239983702017 @default.
• W2023998370 countsByYear W20239983702018 @default.
• W2023998370 countsByYear W20239983702019 @default.
• W2023998370 countsByYear W20239983702020 @default.
• W2023998370 countsByYear W20239983702021 @default.
• W2023998370 countsByYear W20239983702022 @default.
• W2023998370 countsByYear W20239983702023 @default.
• W2023998370 crossrefType "journal-article" @default.
• W2023998370 hasAuthorship W2023998370A5007076175 @default.
• W2023998370 hasAuthorship W2023998370A5013463417 @default.
• W2023998370 hasAuthorship W2023998370A5031384782 @default.
• W2023998370 hasAuthorship W2023998370A5037303670 @default.
• W2023998370 hasAuthorship W2023998370A5046400409 @default.
• W2023998370 hasAuthorship W2023998370A5062173340 @default.
• W2023998370 hasAuthorship W2023998370A5065710640 @default.
• W2023998370 hasAuthorship W2023998370A5087988526 @default.
• W2023998370 hasConcept C121608353 @default.
• W2023998370 hasConcept C126322002 @default.
• W2023998370 hasConcept C126894567 @default.
• W2023998370 hasConcept C188816634 @default.
• W2023998370 hasConcept C207103383 @default.
• W2023998370 hasConcept C2776235491 @default.
• W2023998370 hasConcept C2780192828 @default.
• W2023998370 hasConcept C2781406297 @default.
• W2023998370 hasConcept C2908647359 @default.
• W2023998370 hasConcept C29456083 @default.
• W2023998370 hasConcept C44249647 @default.
• W2023998370 hasConcept C50382708 @default.
• W2023998370 hasConcept C71924100 @default.
• W2023998370 hasConcept C99454951 @default.
• W2023998370 hasConceptScore W2023998370C121608353 @default.
• W2023998370 hasConceptScore W2023998370C126322002 @default.
• W2023998370 hasConceptScore W2023998370C126894567 @default.
• W2023998370 hasConceptScore W2023998370C188816634 @default.
• W2023998370 hasConceptScore W2023998370C207103383 @default.
• W2023998370 hasConceptScore W2023998370C2776235491 @default.
• W2023998370 hasConceptScore W2023998370C2780192828 @default.
• W2023998370 hasConceptScore W2023998370C2781406297 @default.
• W2023998370 hasConceptScore W2023998370C2908647359 @default.
• W2023998370 hasConceptScore W2023998370C29456083 @default.
• W2023998370 hasConceptScore W2023998370C44249647 @default.
• W2023998370 hasConceptScore W2023998370C50382708 @default.
• W2023998370 hasConceptScore W2023998370C71924100 @default.
• W2023998370 hasConceptScore W2023998370C99454951 @default.
• W2023998370 hasIssue "4" @default.
• W2023998370 hasLocation W20239983701 @default.
• W2023998370 hasLocation W20239983702 @default.

• next